CN1672504A - Mixed pig feed and its feeding method - Google Patents
Mixed pig feed and its feeding method Download PDFInfo
- Publication number
- CN1672504A CN1672504A CNA2005100330233A CN200510033023A CN1672504A CN 1672504 A CN1672504 A CN 1672504A CN A2005100330233 A CNA2005100330233 A CN A2005100330233A CN 200510033023 A CN200510033023 A CN 200510033023A CN 1672504 A CN1672504 A CN 1672504A
- Authority
- CN
- China
- Prior art keywords
- feed
- pigs
- cysteamine
- feeding
- feeding method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 23
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 50
- 241000282887 Suidae Species 0.000 claims abstract description 43
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 claims abstract description 39
- 229960003151 mercaptamine Drugs 0.000 claims abstract description 38
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 28
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 12
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 12
- 235000001014 amino acid Nutrition 0.000 claims description 28
- 150000001413 amino acids Chemical class 0.000 claims description 28
- 239000011782 vitamin Substances 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 235000013619 trace mineral Nutrition 0.000 claims description 4
- 239000011573 trace mineral Substances 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 abstract description 36
- 230000000694 effects Effects 0.000 abstract description 14
- 238000011161 development Methods 0.000 abstract description 10
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 150000001875 compounds Chemical class 0.000 abstract description 8
- 235000015097 nutrients Nutrition 0.000 abstract description 8
- 230000001766 physiological effect Effects 0.000 abstract description 8
- 235000015277 pork Nutrition 0.000 abstract description 5
- 102000018997 Growth Hormone Human genes 0.000 abstract description 4
- 108010051696 Growth Hormone Proteins 0.000 abstract description 4
- 239000000122 growth hormone Substances 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 108090000623 proteins and genes Proteins 0.000 description 27
- 235000018102 proteins Nutrition 0.000 description 25
- 102000004169 proteins and genes Human genes 0.000 description 25
- 238000012360 testing method Methods 0.000 description 21
- 235000016709 nutrition Nutrition 0.000 description 20
- 230000035764 nutrition Effects 0.000 description 13
- 239000000463 material Substances 0.000 description 7
- 230000002354 daily effect Effects 0.000 description 6
- 230000033764 rhythmic process Effects 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 102000005157 Somatostatin Human genes 0.000 description 4
- 108010056088 Somatostatin Proteins 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 235000020997 lean meat Nutrition 0.000 description 4
- 244000144972 livestock Species 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 4
- 229960000553 somatostatin Drugs 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000032258 transport Effects 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 3
- 239000003674 animal food additive Substances 0.000 description 3
- 235000014590 basal diet Nutrition 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000003307 slaughter Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 235000019728 animal nutrition Nutrition 0.000 description 2
- 235000021052 average daily weight gain Nutrition 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000000955 neuroendocrine Effects 0.000 description 2
- 235000006180 nutrition needs Nutrition 0.000 description 2
- 235000003170 nutritional factors Nutrition 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 230000007180 physiological regulation Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 108010092674 Enkephalins Proteins 0.000 description 1
- 102400000921 Gastrin Human genes 0.000 description 1
- 108010052343 Gastrins Proteins 0.000 description 1
- 102400000321 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 230000000779 depleting effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000000607 neurosecretory system Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 102000037983 regulatory factors Human genes 0.000 description 1
- 108091008025 regulatory factors Proteins 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
Landscapes
- Fodder In General (AREA)
Abstract
本发明涉及一种猪用预混料饲料及猪的饲喂方法。所述预混饲料包含生物肽和半胱胺。其中,生物肽包括大豆蛋白肽等,有利于增加生长肥育猪生长发育速度;半胱胺为一种生长激素调节剂,能改善猪肉的品质。所述饲料包括预混料、浓缩料和全价配合饲料。将生物肽和半胱胺按一定比率混合,其效果远大于单独使用大豆蛋白肽或半胱胺的效果。它们之间存在相互促进而增大生理效应的作用。所述饲喂方法采用每隔3~15天,甚至于间隔更长的时间。本发明提供的猪用饲料可促进生长肥育猪的生长速度和改善猪胴体的品质。本发明提供的饲喂方法可使营养物质投放的时机和动物体内生理活动规律相配合,且可极大的节约饲养成本,使得昂贵的生物肽和半胱胺在生产中推广使用而成为可能。The invention relates to a premix feed for pigs and a feeding method for pigs. The premixed feed contains biological peptides and cysteamine. Among them, biological peptides include soybean protein peptides, which are beneficial to increase the growth and development speed of growing and finishing pigs; cysteamine is a growth hormone regulator, which can improve the quality of pork. The feed includes premixed feed, concentrated feed and complete compound feed. The effect of mixing biological peptides and cysteamine in a certain ratio is much greater than that of using soybean protein peptide or cysteamine alone. There is mutual promotion between them to increase the physiological effect. The feeding method is adopted every 3 to 15 days, or even longer intervals. The feed for pigs provided by the invention can promote the growth rate of growing and finishing pigs and improve the quality of pig carcasses. The feeding method provided by the invention can match the timing of feeding nutrients with the physiological activity of animals, and can greatly save feeding costs, making it possible to popularize and use expensive biological peptides and cysteamines in production.
Description
技术领域technical field
本发明涉及一种猪用预混料饲料。The invention relates to a premix feed for pigs.
本发明还涉及一种猪的饲喂方法。The invention also relates to a feeding method for pigs.
背景技术Background technique
猪场主希望通过在猪的饲料添加某种或某些物质来促进猪的生长发育速度和不断改善猪肉的品质来达到其商业的利益目标,这对饲料营养学界形成了一种持续性的压力。Pig farmers hope to achieve their commercial interest goals by adding certain substances to pig feed to promote the growth and development of pigs and continuously improve the quality of pork, which has formed a continuous pressure on the feed nutrition industry .
前一段时间,某些商人把一些有害于人体健康的,例如“瘦肉精”之类的违禁品,用于促进猪生长发育的速度,给消费者的健康带来了极大的危害。在国家禁止使用任何有害于人体健康的猪的饲料添加剂之后,饲料营养学界在更加尊重动物本身的生长发育规律的指导下,将目前的注意力主要集中在“什么样的营养物质和什么样的营养物质的组合能最大限度地提高动物的生长发育速度和改善猪肉的品质”。自然,这些营养物质被动物吸收后。已被证实不会对人体健康造成间接危害的。Some time ago, some businessmen used some prohibited substances harmful to human health, such as "lean meat essence", to promote the growth and development of pigs, which brought great harm to the health of consumers. After the state banned the use of any pig feed additives that are harmful to human health, the feed nutrition community focused on "what kind of nutrients and what kind of The combination of nutrients can maximize the growth rate of animals and improve the quality of pork." Naturally, these nutrients are absorbed by the animal. It has been proven that it will not cause indirect harm to human health.
从二十世纪九十年代开始,国内外设计饲料配方或指导畜牧生产一般依据的是理想蛋白质模式(IP)和理想蛋白质可消化氨基酸模式(IP-DAAP),这些营养模式来源于传统的动物营养理论中所一直认为的:蛋白质在动物体内是经过蛋白质——水解——游离氨基酸和寡肽——寡肽在肽酶作用下水解——游离氨基酸而最终被动物体吸收、转化或沉积。认为饲料中的蛋白质必须经过消化酶水解成游离氨基酸才能被动物吸收利用,动物对蛋白质的需要即是对氨基酸的需要;动物生长的氨基酸需要量可以由动物体蛋白质的氨基酸组成来确定,日粮氨基酸只要保持平衡,氨基酸就能被动物机体有效地利用。蛋白质营养价值符合“木桶原理”,即其中第一限制性氨基酸含量最终决定该蛋白质生物学价值。这一理论的应用大大提高了畜禽的生长性能和蛋白质的利用率、节约了蛋白资源(配合饲料中粗蛋白质的水平可降低2-3%),同时减少了粪尿中氮的排出,使畜牧生产产生了巨大的经济效益和生态效益。Since the 1990s, the design of feed formula or guidance of animal husbandry production at home and abroad is generally based on the ideal protein model (IP) and the ideal protein digestible amino acid model (IP-DAAP). These nutritional models are derived from traditional animal nutrition. It is always believed in the theory that protein in the animal body undergoes protein-hydrolysis-free amino acids and oligopeptides-oligopeptides are hydrolyzed by peptidase-free amino acids and are finally absorbed, transformed or deposited by the body. It is believed that the protein in the feed must be hydrolyzed into free amino acids by digestive enzymes before it can be absorbed and utilized by animals. The animal's need for protein is the need for amino acids; As long as amino acids are kept in balance, amino acids can be effectively used by animal organisms. The nutritional value of protein conforms to the "barrel principle", that is, the content of the first limiting amino acid in it ultimately determines the biological value of the protein. The application of this theory greatly improves the growth performance of livestock and poultry and the utilization rate of protein, saves protein resources (the level of crude protein in compound feed can be reduced by 2-3%), and reduces the excretion of nitrogen in feces and urine at the same time, so that Livestock production has produced huge economic and ecological benefits.
但是,近年来的大量研究表明,不同来源的日粮蛋白质,尽管氨基酸组成相同,但利用率却存在明显差异。同时动物对饲料中各种氨基酸的利用程度并不完全受单一限制性氨基酸水平的影响,即不完全遵守“木桶原理”;而且当动物采食以理想氨基酸模式配制的混合日粮或按氨基酸平衡的低蛋白日粮时,并不能获得最佳的生产性能,由此,传统的蛋白质代谢理论——动物蛋白营养既是氨基酸营养的观点受到了挑战,一种独立于氨基酸转运的蛋白质代谢新途径——小肽营养代谢新途径正受到广泛关注。However, a large number of studies in recent years have shown that dietary protein from different sources, although the amino acid composition is the same, but there are significant differences in utilization. At the same time, animals' utilization of various amino acids in the feed is not completely affected by the level of a single limiting amino acid, that is, the "barrel principle" is not fully followed; Therefore, the traditional theory of protein metabolism—the idea that animal protein nutrition is amino acid nutrition is challenged, and a new pathway of protein metabolism independent of amino acid transport ——The new pathway of nutritional metabolism of small peptides is receiving widespread attention.
自从分别观察到动物肠道能够吸收小肽,循环血液中确有大量小肽存在。有证据证明肽的吸收能影响蛋白质的合成与降解,且对动物生产发育和机体的免疫产生作用。肽类能被动物完整吸收并独立于氨基酸转运载体的观点开始被人们所重视,认识到动物吸收、转化或沉积蛋白质的途径除了有蛋白质经过消化酶水解成游离氨基酸而能被动物吸收之外,还有利用蛋白质水解为寡肽,寡肽进一步分解为游离氨基酸和小肽而被吸收这一途径,而且小肽的转运和吸收完全区别于游离氨基酸的转运和吸收,动物对小肽的吸收比对游离氨基酸的吸收更完整。营养界已普遍认识到传统的理想蛋白质模式或理想蛋白质可消化氨基酸模式并不能完全代表动物的蛋白营养,以此作为理论依据设计配方所生产出的饲料并不都能使动物获得最佳生产性能;而氨基酸若以小肽形式被吸收时,其向肠细胞中传递比游离氨基酸快,对能量的依赖程度也较低,同时具有载体不易饱和等特点;当日粮以小肽形式作为氮源时,机体蛋白质的沉积高于相应的氨基酸日粮或完整蛋白质日粮。因此,动物的蛋白营养不应仅仅是氨基酸的平衡,而同时应该包含小肽营养的平衡。由此,传统的氨基酸营养理论受到挑战,对小肽营养及小肽产品的研究也在近几年成为动物营养研究的热点。Since the small peptides were observed separately in the intestinal tract of animals, there are indeed large amounts of small peptides in the circulating blood. There is evidence that the absorption of peptides can affect the synthesis and degradation of proteins, and have effects on animal production and development and the body's immunity. The view that peptides can be completely absorbed by animals and independent of amino acid transport carriers has begun to be valued by people. It is recognized that the way animals absorb, transform or deposit proteins can be absorbed by animals in addition to the way that proteins are hydrolyzed by digestive enzymes into free amino acids. There is also the way of using protein to be hydrolyzed into oligopeptides, and oligopeptides are further decomposed into free amino acids and small peptides to be absorbed, and the transport and absorption of small peptides are completely different from the transport and absorption of free amino acids. The absorption ratio of animals to small peptides The absorption of free amino acids is more complete. The nutrition community has generally recognized that the traditional ideal protein model or ideal protein digestible amino acid model cannot fully represent the protein nutrition of animals, and the feed produced by designing formulas based on this theory does not always enable animals to achieve optimal production performance ; and if the amino acid is absorbed in the form of small peptides, it will be transferred to the intestinal cells faster than free amino acids, and the dependence on energy is also lower. At the same time, it has the characteristics that the carrier is not easy to saturate; , the deposition of body protein is higher than the corresponding amino acid diet or complete protein diet. Therefore, the protein nutrition of animals should not only be the balance of amino acids, but should also include the balance of small peptide nutrition. As a result, the traditional theory of amino acid nutrition has been challenged, and the research on small peptide nutrition and small peptide products has also become a hot spot in animal nutrition research in recent years.
半胱胺(Cysteamine,CS)又称β-巯基乙胺,分子式为H2N-CH2-CH2-SH。半胱胺相当于半胱氨酸的脱羧产物,是辅酶A分子的组成部分,是动物体内的生物活性物质。近年来,半胱胺作为一种新型的动物机体营养性功能调节添加剂而受到许多国家、研究机构的关注,在美国已申请专利,并在畜禽生产上得到应用。Cysteamine (CS), also known as β-mercaptoethylamine, has a molecular formula of H 2 N-CH 2 -CH 2 -SH. Cysteamine is equivalent to the decarboxylation product of cysteine, a component of coenzyme A molecule, and a biologically active substance in animals. In recent years, cysteamine has attracted the attention of many countries and research institutions as a new type of additive for regulating the nutritional function of animal organisms. It has applied for a patent in the United States and has been applied in livestock and poultry production.
半胱胺的促生长作用主要是通过耗竭动物体内的生长抑素(Somatostain,SS)来实现的,生长抑素是广泛存在于动物各种组织中的一种调节肽,尤其是在神经系统和消化道内浓度较高,有14、25和28氨基酸残基等多肽形式,并以14肽(SS-14)为主。The growth-promoting effect of cysteamine is mainly achieved by depleting somatostatin (Somatostain, SS) in animals. Somatostatin is a regulatory peptide widely present in various tissues of animals, especially in the nervous system and The concentration in the digestive tract is relatively high, and there are peptide forms such as 14, 25 and 28 amino acid residues, and the 14 peptide (SS-14) is the main one.
在动物体内生长抑素抑制生长激素(Growth Hormone,GH)的生成和释放,并对多种促进生长的激素,如胰岛素,胰高血糖素和促甲状腺激素的分泌有抑制作用。研究表明,半胱胺对离体及在体内的各种组织内的生长抑素免疫活性均有特异的耗竭作用,口服半胱胺后导致生物体内GH、IGF-I、甲状腺素、加压素、脑啡呔、胰岛素、胃泌素等的分泌量增加。是一种较好的通过神经内分泌途径调控动物生长的生理调节剂。据报道,在动物饲料中添加半胱胺,猪的日增重提高2.8%~11.8%,料肉比降低2.1%~8.1%成本。同时,它还能影响猪的脂肪代谢,影响脂肪在体内的分布。改善猪的体型和猪肉的品质。In animals, somatostatin inhibits the production and release of growth hormone (GH), and inhibits the secretion of various growth-promoting hormones, such as insulin, glucagon and thyroid-stimulating hormone. Studies have shown that cysteamine has a specific depletion effect on the immune activity of somatostatin in various tissues in vitro and in vivo, and oral administration of cysteamine can lead to GH, IGF-I, thyroxine, and vasopressin in vivo. , enkephalin, insulin, gastrin and other increased secretion. It is a better physiological regulator for regulating animal growth through neuroendocrine pathway. According to reports, when cysteamine is added to animal feed, the daily gain of pigs can be increased by 2.8% to 11.8%, and the cost of feed to meat can be reduced by 2.1% to 8.1%. At the same time, it can also affect the fat metabolism of pigs and affect the distribution of fat in the body. Improve pig size and pork quality.
猪的生长发育过程是在其遗传基因的控制下,体内的神经-内分泌系统的调节下的一个平衡而又协调的过程。这种协调性是动物经过对特定的环境的长期适应和经历了千万年的进化而以其特有的基因组合或其它人类尚未知的形式而定格。这种定格其中一个主要的表现形式是以内分泌的特有节律或者其它生理调节因子分泌的节律来控制猪的生长发育的。The growth and development process of pigs is a balanced and coordinated process under the control of their genetic genes and the regulation of the neuro-endocrine system in the body. This kind of coordination is fixed by animals with their unique gene combination or other unknown forms after long-term adaptation to a specific environment and evolution for tens of millions of years. One of the main manifestations of this freeze-frame is the specific rhythm of endocrine or the rhythm of secretion of other physiological regulatory factors to control the growth and development of pigs.
因而,以影响神经内分泌途径调控动物生长的生理调节的饲料添加剂要考虑生命体的固有的生命节律。Therefore, feed additives that affect the physiological regulation of animal growth by affecting neuroendocrine pathways should consider the inherent life rhythm of living organisms.
发明内容Contents of the invention
本发明的目的在于提供一种猪用的预混料,含有该预混料的饲料可促进生长肥育猪的生长速度和改善猪胴体的品质。The purpose of the present invention is to provide a premixed feed for pigs, the feed containing the premixed feed can promote the growth rate of growing and finishing pigs and improve the quality of pig carcasses.
本发明的另一个目的在于提供一种猪的新的饲喂方法,该方法可使含有该预混料的营养物质投放的时机和动物体内生理活动规律相配合,且可极大的节约该预混料内特殊营养物质投放的成本。Another object of the present invention is to provide a new feeding method for pigs, which can match the timing of feeding the nutrient substance containing the premix with the physiological activity of the animal, and can greatly save the premix. The cost of adding special nutrients in the feed.
本发明提供了一种猪用饲料,该饲料包含生物肽和半胱胺。取名为“律动源”。其中,生物肽包括大豆蛋白肽等,有利于增加生长肥育猪生长发育速度;半胱胺为一种调控动物生长的生理调节剂,还能改善猪肉的品质。The invention provides a feed for pigs, which contains biological peptide and cysteamine. Name it "Rhythm Source". Among them, biological peptides include soybean protein peptides, which are beneficial to increase the growth and development speed of growing and finishing pigs; cysteamine is a physiological regulator that regulates animal growth, and can also improve the quality of pork.
所述饲料的饲喂对象为生长肥育猪。The feeding objects of the feed are growing and finishing pigs.
本发明将不同营养途径的两种物质——生物肽和半胱胺按一定比率混合使用,其效果远大于两者单独使用。The present invention mixes two substances of different nutritional pathways—biological peptide and cysteamine in a certain ratio, and its effect is far greater than that of the two alone.
本发明所述饲料可按照本领域常规方法制备。The feed described in the present invention can be prepared according to conventional methods in the art.
进一步的,本发明所述饲料包括预混料、浓缩料和全价配合饲料。Further, the feed of the present invention includes premixed feed, concentrated feed and complete compound feed.
本发明所述饲料是指一般能被动物食用又能给动物某种或多种营养的物质。The feedstuff mentioned in the present invention refers to the material that can be generally eaten by animals and can provide some kind of nutrition to animals.
本发明所述预混料是添加剂预混合饲料的简称,它是将一种或多种微量组分(包括各种微量矿物元素、各种维生素、合成氨基酸、某些药物等添加剂)与稀释剂或载体按要求配比,均匀混合后制成的中间型配合饲料产品。预混料是全价配合饲料的一种重要组分。The premixed material of the present invention is the abbreviation of additive premixed feed, and it is the abbreviation of one or more microcomponents (comprising various trace mineral elements, various vitamins, synthetic amino acids, certain drugs and other additives) and diluent Or the carrier is formulated according to the requirements, and the intermediate type compound feed product is made after uniform mixing. Premix is an important component of complete compound feed.
本发明所述浓缩料是指全价饲料中除去能量饲料的剩余部分,国外称平衡用配合饲料,也称蛋白质—维生素补充饲料。主要包括蛋白质饲料、常量矿物质饲料和添加剂预混合饲料。The concentrated feed of the present invention refers to the remaining part of the full-price feed except the energy feed, which is called balanced compound feed abroad, and also called protein-vitamin supplement feed. It mainly includes protein feed, constant mineral feed and additive premixed feed.
本发明所述全价配合饲料(简称为全价料)也称全日粮配合饲料。它能直接用于饲喂饲养对象,能全面满足饲喂对象的营养需要,主要包括能量饲料、蛋白质饲料和矿物质等营养物质。The full-price compound feed of the present invention (abbreviated as full-price feed) is also called full-ration compound feed. It can be directly used to feed the feeding objects, and can fully meet the nutritional needs of the feeding objects, mainly including nutrients such as energy feed, protein feed and minerals.
优选的,所述猪用饲料还可进一步包含维生素、氨基酸和微量元素。Preferably, the feed for pigs may further contain vitamins, amino acids and trace elements.
优选的,所述生物肽为大豆蛋白肽。Preferably, the biological peptide is soybean protein peptide.
在每吨全价料中至少添加所述预混料1公斤。Add at least 1 kg of the premixed material per ton of full-price material.
并且使最终配成的全价日粮中每吨所含的成分保证如下:And the ingredients contained in each ton of the final full-price ration are guaranteed as follows:
成分 用量
生物肽 500g
半胱胺 200g
复合维生素 100g
色氨酸 50g
苯丙氨酸 20gPhenylalanine 20g
复合微量元素 130g back
其中1公斤“律动源”含有:1 kg of "Rhythm Source" contains:
Cu:2600-7500mg VA≥180000IU Cu: 2600-7500mg
Fe≥2600mg VE≥900mg
基本Mn≥1000mg VB1≥30mg Basic Mn≥1000mg Basic Mn≥1000mg Basic Mn≥1000mg
Zn≥2100mg VB2≥95mgZn≥2100mg VB2≥95mg
Se:3.5mg VB12≥300mgSe: 3.5mg VB12≥300mg
在实际生产时,还可以将上所述预混料稀释成使用量为0.1%-5.0%的预混料。也就是说,可以根据实际情况所需,将每吨全价日粮中可以添加本发明所述预混料1kg至50kg不等。并使得全价料日粮的基本营养的各种营养成分既符合国家也符合企业的标准。In actual production, the above-mentioned premix can also be diluted to a premix with a usage amount of 0.1%-5.0%. That is to say, according to actual needs, 1 kg to 50 kg of the premix described in the present invention can be added per ton of the full-price ration. And make the various nutritional ingredients of the basic nutrition of the complete feed ration meet the standards of the country and the enterprise.
本发明进行的实验表明:The experiment that the present invention carries out shows:
1、当饲料中添加生物肽时,可提高生长肥育猪的日增重,降低料重比。1. When biological peptides are added to the feed, it can increase the daily gain of growing and finishing pigs and reduce the feed-to-weight ratio.
2、当饲料中添加半胱胺时,可促进生长肥育猪的生长发育速率,可提高胴体瘦肉率,降低脂肪比率。2. When cysteamine is added to the feed, it can promote the growth and development rate of growing and finishing pigs, increase the carcass lean meat rate, and reduce the fat ratio.
3、将生物肽和半胱胺按一定比率混合,其效果远大于单独使用大豆蛋白肽或半胱胺的效果。它们之间可能存在相互促进而增大生理效应的作用。3. The effect of mixing biological peptide and cysteamine in a certain ratio is far greater than that of using soybean protein peptide or cysteamine alone. There may be mutual promotion between them to increase the physiological effect.
根据本发明的另一个方面,本发明提供了一种猪的饲喂方法,所述饲喂方法用包含生物肽和半胱胺的饲料进行饲喂。According to another aspect of the present invention, the present invention provides a feeding method for pigs, wherein the feeding method is fed with a feed containing biological peptides and cysteamine.
进一步的,所述饲喂方法采用每隔3~15天,甚至于间隔更长的时间饲喂一次的方法,即“击靶式饲喂法”,所用饲料包含生物肽和半胱胺。例如,可每隔3天、5天、7天、8天、10天或15天饲喂一次。Further, the feeding method adopts a method of feeding once every 3-15 days, or even longer intervals, that is, "target feeding method", and the feed used contains biological peptides and cysteamine. For example, it may be fed every 3, 5, 7, 8, 10 or 15 days.
更进一步的,每隔7天饲喂一次。具体地说,可先将预混料配成全价料后,再予饲喂。Further, feed once every 7 days. Specifically, the premix can be made into a full price feed before feeding.
本发明的实验结果表明,除了满足动物生长发育所需的基本营养需要“天天饲喂”外,一些和动物体内特殊生理活动相关的营养因子的饲喂不但不需要“天天饲喂”,而且可根据我们对动物生理活动的规律,根据动物生长发育的不同阶段,根据不同的营养组合,采用每隔3天、5天、8天、10天或15天,甚至于间隔更长的时间饲喂,不但能提高营养因素的生理作用,而且也使这些饲喂昂贵的生理调节剂饲养成本相应降低3、5、8......倍。我们把这种饲喂办法称之为“击靶式饲喂法”。The experimental results of the present invention show that, in addition to satisfying the basic nutritional needs of animals for growth and development by "feeding every day", the feeding of some nutritional factors related to special physiological activities in animals not only does not require "feeding every day", but also can According to our laws of animal physiological activities, according to different stages of animal growth and development, according to different nutritional combinations, feeding every 3 days, 5 days, 8 days, 10 days or 15 days, or even longer intervals , not only can improve the physiological effects of nutritional factors, but also reduce the feeding cost of these expensive physiological regulators by 3, 5, 8... times. We call this feeding method "target feeding".
所述饲喂方法不但可使营养物质投放的时机和动物体内生理活动规律相配合,而且可极大的节约饲养成本,使得昂贵的生物肽和半胱胺在生产中推广使用而成为可能。The feeding method can not only match the timing of feeding nutrients with the laws of physiological activities in animals, but also can greatly save feeding costs, making it possible to popularize and use expensive biological peptides and cysteamines in production.
本发明中所使用的物质均符合国家饲料安全标准。The materials used in the present invention all meet the national feed safety standards.
为了更好地理解本发明的本质,下面通过对本发明较佳实施方式的描述,详细说明但不限制本发明。In order to better understand the essence of the present invention, the following describes the preferred embodiments of the present invention in detail but does not limit the present invention.
具体实施方式Detailed ways
本发明所用的试验材料,如无特别说明,均为市售购买产品。The test materials used in the present invention, unless otherwise specified, are commercially available products.
证明生物多肽营养的试验 Experiments to prove the nutrition of biological peptides
【实施例1】猪群饲喂生物多肽和其它蛋白日量的对比试验[Example 1] Contrast test of pigs feeding biological polypeptide and other protein daily amounts
试验组饲喂大豆蛋白肽(无锡正大畜禽有限公司提供,运用现代生物霉工程技术从裂解大豆蛋白中提取的具有生物活性的6~8个氨基酸组成的短肽);The experimental group was fed with soybean protein peptides (provided by Wuxi Zhengda Livestock and Poultry Co., Ltd., a biologically active short peptide consisting of 6 to 8 amino acids extracted from cracked soybean protein using modern biological mold engineering technology);
对照组饲喂普通蛋白饲料(不含生物多肽)。The control group was fed with ordinary protein feed (without biological polypeptide).
试验结果见表1。由结果可知,试验组猪的平均日增重提高14.76%,料重比下降7.1%。The test results are shown in Table 1. It can be seen from the results that the average daily gain of pigs in the test group increased by 14.76%, and the feed-to-weight ratio decreased by 7.1%.
表1 猪群饲喂“小肽”和其它蛋白日量的对比试验
证明半胱胺(CS)生理调节作用的试验 Experiments Demonstrating Physiological Regulation of Cysteamine (CS)
【实施例2】半胱胺对生长肥育猪胴体性状的影响[Example 2] Effect of cysteamine on carcass traits of growing and finishing pigs
本实验研究用经过包被处理的半胱胺(CS)作为饲料添加剂,观察间断性添加和持续添加对生长肥育猪生长发育和胴体品质的影响。In this experiment, coated cysteamine (CS) was used as a feed additive to observe the effects of intermittent addition and continuous addition on growth and carcass quality of growing-finishing pigs.
试验方法:选择体重35kg左右的杜×大×长三元杂交猪288头,按体重、性别分成3组,每组3个重复,每个重复32头,对照组:生长期和肥育期分别饲喂相应的基础日粮(表1);试验I组:间断性添加,每6天添加1次;试验II组,持续添加。Test method: Select 288 Du×Da×Chang three-way cross-breed pigs weighing about 35kg, divide them into 3 groups according to body weight and gender, and each group has 3 replicates, with 32 pigs per replicate. Feed the corresponding basal diet (Table 1); test group I: add intermittently, once every 6 days; test group II, continue to add.
CS不同添加方式对屠宰率、胴体瘦肉率、脂肪率、眼肌面积和第10肋背膘厚的影响见表2。由结果可知,半胱胺的不同添加方式均能提高胴体瘦肉率,降低脂肪比率;间断性添加和持续添加半胱胺的作用没有明显区别。The effects of different addition methods of CS on slaughter percentage, carcass lean meat percentage, fat percentage, eye muscle area and backfat thickness of the 10th rib are shown in Table 2. It can be known from the results that different addition methods of cysteamine can increase carcass lean meat percentage and reduce fat ratio; there is no significant difference between intermittent addition and continuous addition of cysteamine.
表2 半胱胺对生长肥育猪胴体性状的影响
包含生物肽和半胱胺的预混料的制备 Preparation of premixes containing biopeptides and cysteamine
【实施例3】[Example 3]
I、配方:I. Formula:
成分 用量
生物肽(≥30%) 500gBiological peptide (≥ 30 %) 500g
半胱胺(≥27%) 200g
复合维生素(≥40%) 100gComposite vitamin (≥40 %) 100g
色氨酸(≥98%) 50g
苯丙氨酸(≥98%) 20gPhenylalanine (≥98%) 20g
复合微量元素 130gComposite trace element 130g
其中:(每公斤“律动源”斤含有) Among them: (Contains per kilogram of "Rhythm Source" jin)
Cu:2600-7500mg VA≥180000IU
Fe≥2600mg VE≥900mg
Mn≥1000mg VB1≥30mgMn≥1000mg VB1≥30mg
Zn≥2100mg VB2≥95mgZn≥2100mg VB2≥95mg
Se:4mg VB12≥0.3mgSe: 4mg VB12≥0.3mg
II、制备方法:按照本领域常规技术制备。II. Preparation method: prepared according to conventional techniques in the art.
证明生物多肽和半胱胺具有协同作用 Prove that biological peptides and cysteamine have a synergistic effect
【实施例4】生物肽和半胱胺混合使用对生长肥育猪胴体性状的影响[Example 4] Effects of mixed use of biological peptides and cysteamine on carcass traits of growing and finishing pigs
试验组:将大豆蛋白肽和半胱胺按重量比2.5∶1混合,每隔7天使用一次;对照组:非试验期间,对照组和试验组猪只实行自由采食,饲喂基础日粮。试验期间,试验组猪只饲喂试验料,每头每天采食3.01g(猪场也可实行自由采食);对照组猪只依旧饲喂基础日粮,自由采食。Test group: Mix soybean protein peptide and cysteamine at a weight ratio of 2.5:1, and use it once every 7 days; Control group: During the non-test period, the pigs in the control group and the test group were fed ad libitum and fed basal diet . During the test period, the pigs in the test group were fed with the test feed, 3.01g per head per day (the pig farms can also implement ad libitum feeding); the pigs in the control group were still fed with the basal diet and ad libitum.
饲喂日粮推荐方案 Recommended Diet
试验料 基础日粮
玉米 62.0 62.0 62.0 62.0
豆粕 22.0 22.0Soybean Meal 22.0 22.0
麸皮 12.0 12.0Bran 12.0 12.0
律动源 4.0 /
大猪预混料 / 4.0 &&#; & && && &&&&& 4.0
合计 100.0 100.0Total 100.0 100.0
结果见表3。The results are shown in Table 3.
由结果可知,试验组猪比对照组猪的平均口增重提高了15.3%,料肉比也高于对照组猪3.7%,在随后的10多次实验皆取得相似的结果;平均日增重都提高了5~15%不等,而且猪的体形健美,皮毛光亮,收腹效果明显,屠宰后的肉色均匀,肉质鲜嫩。结果表明将大豆蛋白肽和半胱胺按一定比率混合,其效果远大于单独使用大豆蛋白肽或半胱胺的效果。It can be seen from the results that the average mouth weight gain of the test group pigs was 15.3% higher than that of the control group pigs, and the feed-to-meat ratio was also 3.7% higher than that of the control group pigs. Similar results were obtained in more than 10 subsequent experiments; the average daily weight gain All of them have increased by 5-15%. Moreover, the pigs are in good shape, with bright fur and obvious abdominal tightening effect. After slaughtering, the meat color is uniform and the meat is tender. The results show that the effect of mixing soybean protein peptide and cysteamine in a certain ratio is much greater than that of using soybean protein peptide or cysteamine alone.
表3 大豆蛋白肽和半胱胺混合使用对生长肥育猪胴体性状的影响
以上对本发明较佳实施方式的描述并不限制本发明,本领域技术人员可以根据本发明作出各种改变或变形,只要不脱离本发明的精神,均应属于本发明所附权利要求的范围。The above description of the preferred embodiments of the present invention does not limit the present invention, and those skilled in the art can make various changes or deformations according to the present invention, as long as they do not depart from the spirit of the present invention, all should belong to the scope of the appended claims of the present invention.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100330233A CN100381046C (en) | 2005-01-25 | 2005-01-25 | A kind of premix feed for pigs and feeding method for pigs |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100330233A CN100381046C (en) | 2005-01-25 | 2005-01-25 | A kind of premix feed for pigs and feeding method for pigs |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1672504A true CN1672504A (en) | 2005-09-28 |
CN100381046C CN100381046C (en) | 2008-04-16 |
Family
ID=35045478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100330233A Expired - Lifetime CN100381046C (en) | 2005-01-25 | 2005-01-25 | A kind of premix feed for pigs and feeding method for pigs |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100381046C (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008006285A1 (en) * | 2006-07-07 | 2008-01-17 | Jianhui Chen | Stabilization compositions for cysteamine and its hydrochloride and process methods related |
CN101884366A (en) * | 2010-07-20 | 2010-11-17 | 郭军 | Feed additive |
CN101044881B (en) * | 2006-03-28 | 2011-02-02 | 广东腾骏动物药业股份有限公司 | Feed additive and production method thereof |
CN101213951B (en) * | 2007-12-28 | 2011-08-31 | 北京中赛天地科技有限责任公司 | Emission reduction drying type cultivation method for producing non-antibiotics pork |
CN101040671B (en) * | 2007-04-07 | 2011-09-14 | 乐建来 | Muscle type pig feed |
CN106615771A (en) * | 2016-11-16 | 2017-05-10 | 漳州傲农牧业科技有限公司 | Premix for raising growth hormone level in blood of growing-finishing pigs |
CN107410707A (en) * | 2017-09-21 | 2017-12-01 | 广东鑫肽生物科技股份有限公司 | Pig perfect compound feed containing insect protein and the domestic animal pig pork after its feeding |
CN111869791A (en) * | 2020-07-03 | 2020-11-03 | 辽宁菲迪饲料科技有限责任公司 | Application of cysteamine magnesium as animal feed additive |
-
2005
- 2005-01-25 CN CNB2005100330233A patent/CN100381046C/en not_active Expired - Lifetime
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101044881B (en) * | 2006-03-28 | 2011-02-02 | 广东腾骏动物药业股份有限公司 | Feed additive and production method thereof |
WO2008006285A1 (en) * | 2006-07-07 | 2008-01-17 | Jianhui Chen | Stabilization compositions for cysteamine and its hydrochloride and process methods related |
CN101040671B (en) * | 2007-04-07 | 2011-09-14 | 乐建来 | Muscle type pig feed |
CN101213951B (en) * | 2007-12-28 | 2011-08-31 | 北京中赛天地科技有限责任公司 | Emission reduction drying type cultivation method for producing non-antibiotics pork |
CN101884366A (en) * | 2010-07-20 | 2010-11-17 | 郭军 | Feed additive |
CN101884366B (en) * | 2010-07-20 | 2012-12-05 | 郭军 | Feed additive |
CN106615771A (en) * | 2016-11-16 | 2017-05-10 | 漳州傲农牧业科技有限公司 | Premix for raising growth hormone level in blood of growing-finishing pigs |
CN107410707A (en) * | 2017-09-21 | 2017-12-01 | 广东鑫肽生物科技股份有限公司 | Pig perfect compound feed containing insect protein and the domestic animal pig pork after its feeding |
CN111869791A (en) * | 2020-07-03 | 2020-11-03 | 辽宁菲迪饲料科技有限责任公司 | Application of cysteamine magnesium as animal feed additive |
Also Published As
Publication number | Publication date |
---|---|
CN100381046C (en) | 2008-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104351478A (en) | Composite functional amino acid feed additive and application | |
Murthy et al. | Total sulphur amino acid requirement of the Indian major carp, Labeo rohita (Hamilton) | |
CN106036181A (en) | Meat duck compound feed for improving muscle quality and preparation method thereof | |
CN106879864A (en) | A kind of high efficiency, low cost improves yellow-feather broiler fodder and its application of meat | |
CN101326967A (en) | Composite premix for pigs and preparation method thereof | |
CN101044881A (en) | A kind of feed additive and its production method | |
CN104489258A (en) | Premix feed capable of improving quality of mink fur and increasing feed utilization rate and preparation method of premix feed | |
CN111955620A (en) | Special low-protein feed for laying hens and preparation method and application thereof | |
CN107259186B (en) | A kind of laying hen feed for producing high-calcium and high-zinc nutritious eggs and preparation method thereof | |
CN107996857A (en) | A kind of liquid amino acid vitamine supplement for reducing weaning stress of piglet and preparation method and application | |
CN1672504A (en) | Mixed pig feed and its feeding method | |
CN104543524B (en) | Growing-finishing pig compound feed for reducing concentration of ammonia gas in pigsty | |
CN112167428A (en) | Low-protein amino acid balanced fattening pig compound feed and preparation method thereof | |
CN1810147A (en) | Feed for weaned piglet | |
CN107518202A (en) | A kind of bird feed additive | |
CN106333081B (en) | Feed additive containing amino acid | |
CN107960529A (en) | Marine organisms beneficial bacteria rolls into a ball complex ecological feed addictive | |
KR20070031815A (en) | Livestock raised with feed additives and feed containing these feed additives | |
CN117461753A (en) | Compound premix for improving lean meat percentage of beef cattle and mutton sheep | |
CN109874937A (en) | Low-protein balanced nutrition selenium-enriched ecological feed for growing-finishing pigs | |
CN1568746A (en) | Alkali type zinc chloride feedstuff additive and preparation method thereof | |
CN104313104B (en) | Ionic protein peptide and preparation method and application thereof | |
CN1419840A (en) | Safety meat modifier | |
CN103815200B (en) | Miscellaneous meal-type fermented concentrated feed for pregnant sows | |
CN114938830A (en) | Feed additive for improving lean meat percentage of livestock and poultry based on amino acid and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Premix Inve Nutrition (Shenzhen) Co.,Ltd. Assignor: Li Zhi Contract fulfillment period: 2008.8.25 to 2013.12.31 Contract record no.: 2008440000280 Denomination of invention: Mixed pig feed and its feeding method Granted publication date: 20080416 License type: Exclusive license Record date: 20081020 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.8.25 TO 2013.12.31; CHANGE OF CONTRACT Name of requester: BILIMEI YINGWEI NUTRITION FEEDINGS ( SHENZHEN ) CO Effective date: 20081020 |
|
EM01 | Change of recordation of patent licensing contract |
Change date: 20120328 Contract record no.: 2008440000280 Assignee after: SHENZHEN PREMIXINVE NUTRITION CO.,LTD. Assignee before: Premix Inve Nutrition (Shenzhen) Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN PREMIX INVE NUTRITION CO., LTD. Free format text: FORMER OWNER: LI ZHI Effective date: 20130502 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130502 Address after: 518000, Shenzhen, Guangdong, Baoan District Fuyong street community building road, the first high-tech science and Technology Park Patentee after: SHENZHEN PREMIXINVE NUTRITION CO.,LTD. Address before: 518000 room 1204, Plaza building, 9 District, Baoan District, Guangdong, Shenzhen, Baoan Patentee before: Li Zhi |
|
TR01 | Transfer of patent right |
Effective date of registration: 20230518 Address after: 511500 No. 7, Guangzhou Road, Guangzhou (Qingyuan) Industrial Transfer Industrial Park, Shijiao Town, Qingcheng District, Qingyuan City, Guangdong Province Patentee after: Qingyuan Xiangda Biotechnology Co.,Ltd. Address before: 518000 Building 1, high tech park, Jian'an Road, Tangwei community, Fuyong street, Bao'an District, Shenzhen, Guangdong Patentee before: SHENZHEN PREMIXINVE NUTRITION CO.,LTD. |
|
TR01 | Transfer of patent right | ||
CX01 | Expiry of patent term |
Granted publication date: 20080416 |
|
CX01 | Expiry of patent term |